Vertex Pharmaceuticals Inc 2021 SR
The report highlights Vertex Pharmaceuticals' 2021 progress in corporate responsibility, emphasizing its $3.05 billion investment in R&D and expanded access to cystic fibrosis medicines in over 30 countries. The company achieved a 19.7% reduction in absolute greenhouse gas emissions since 2018, nearing its 2023 target. Vertex also focused on inclusion, diversity, and equity, with women making up 41% of leadership roles and 40% of the board. Additionally, the company and its foundation contributed over $34 million in charitable giving, supporting STEAM education and community health initiatives.
Company: Vertex Pharmaceuticals Inc
Sector: Health Care
Country: United States
Year: 2021
Type: SR
Pages: 36
Vertex Pharmaceuticals Inc
Corporate Responsibility Report
The report highlights Vertex Pharmaceuticals' 2021 progress in corporate responsibility, emphasizing its $3.05 billion investment in R&D and expanded access to cystic fibrosis medicines in over 30 countries. The company achieved a 19.7% reduction in absolute greenhouse gas emissions since 2018, nearing its 2023 target. Vertex also focused on inclusion, diversity, and equity, with women making up 41% of leadership roles and 40% of the board. Additionally, the company and its foundation contributed over $34 million in charitable giving, supporting STEAM education and community health initiatives.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Jan 1, 2021 - Dec 31, 2021
Fiscal Year
2021
Published
Apr 1, 2022
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Water Consumption
Total Waste
Women on Board
Women in Management
Employees